• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺肿瘤发生过程中雌激素受体α和β信使核糖核酸表达的改变

Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis.

作者信息

Leygue E, Dotzlaw H, Watson P H, Murphy L C

机构信息

Department of Biochemistry, University of Manitoba, Faculty of Medicine, Winnipeg, Canada.

出版信息

Cancer Res. 1998 Aug 1;58(15):3197-201.

PMID:9699641
Abstract

Using a multiplex reverse transcription-PCR assay, we compared the relative expression of estrogen receptor (ER) alpha and ER-beta mRNA between adjacent samples of normal breast tissue and matched primary breast tumors obtained from 18 different patients. Within this cohort, 7 tumors were ER negative, and 11 tumors were ER positive, as determined by the ligand binding assay. No differences in the ratio of ER-alpha:ER-beta expression were observed in the ER-negative cohort. However, in the ER-positive cohort, a significantly (P < 0.02) higher ER-alpha:ER-beta ratio was observed in the tumor compared with that of the normal tissue component. Our data revealed that the increase in the ER-alpha:ER-beta ratio was due primarily to a significant (P < 0.05) increase in ER-alpha mRNA expression in conjunction with a lower ER-beta mRNA expression in the tumor compared with that of the normal compartment in some, but not all, ER-positive cases. These results suggest that the role of ER-alpha- and ER-beta-driven pathways and/or their interaction change during breast tumorigenesis.

摘要

我们使用多重逆转录聚合酶链反应(multiplex reverse transcription-PCR)检测法,比较了来自18位不同患者的正常乳腺组织相邻样本与配对原发性乳腺肿瘤中雌激素受体(ER)α和ER-β mRNA的相对表达。在该队列中,通过配体结合试验确定,7例肿瘤为ER阴性,11例肿瘤为ER阳性。在ER阴性队列中,未观察到ER-α:ER-β表达比例的差异。然而,在ER阳性队列中,与正常组织成分相比,肿瘤中ER-α:ER-β比例显著升高(P < 0.02)。我们的数据显示,在部分(并非全部)ER阳性病例中,与正常组织相比,肿瘤中ER-α:ER-β比例的增加主要是由于ER-α mRNA表达显著增加(P < 0.05),同时ER-β mRNA表达降低。这些结果表明,在乳腺肿瘤发生过程中,ER-α和ER-β驱动的信号通路及其相互作用发生了变化。

相似文献

1
Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis.人乳腺肿瘤发生过程中雌激素受体α和β信使核糖核酸表达的改变
Cancer Res. 1998 Aug 1;58(15):3197-201.
2
Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.通过实时聚合酶链反应对乳腺癌中雌激素受体α和β信使核糖核酸表达进行定量分析。
Cancer. 2000 Oct 15;89(8):1732-8. doi: 10.1002/1097-0142(20001015)89:8<1732::AID-CNCR13>3.0.CO;2-2.
3
Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue.雌激素受体β1、β2和β5信使核糖核酸在人乳腺组织中的表达。
Cancer Res. 1999 Mar 15;59(6):1175-9.
4
Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins.人乳腺肿瘤活检组织中雌激素受体-β信使核糖核酸的表达:与类固醇受体状态的关系及孕激素的调节作用
Cancer Res. 1999 Feb 1;59(3):529-32.
5
Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.乳腺癌中雌激素受体α、雌激素受体β、共激活因子和共抑制因子的表达水平。
Clin Cancer Res. 2000 Feb;6(2):512-8.
6
Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer?雌激素受体α和β的共表达:人类乳腺癌的不良预后因素?
Cancer Res. 1999 Feb 1;59(3):525-8.
7
Expression of estrogen receptor beta messenger RNA variant in breast cancer.雌激素受体β信使核糖核酸变异体在乳腺癌中的表达
Cancer Res. 1998 Jan 15;58(2):210-4.
8
Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.雌激素受体α和β信使核糖核酸的差异表达作为卵巢癌发生的潜在标志物。
Cancer Res. 1998 Dec 1;58(23):5367-73.
9
Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.Id4信使核糖核酸与雌激素受体表达:在人正常乳腺上皮和癌中的负相关。
Hum Pathol. 2006 Aug;37(8):1032-41. doi: 10.1016/j.humpath.2006.03.004. Epub 2006 May 22.
10
Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.通过实时定量逆转录-聚合酶链反应分析评估雄激素、雌激素(雌激素受体α和雌激素受体β)和孕激素受体在人前列腺癌中的表达。
Cancer Res. 2001 Mar 1;61(5):1919-26.

引用本文的文献

1
Steroid receptors and coregulators: Dissemination of sex differences and emerging technologies.类固醇受体与共调节因子:性别差异的传播及新兴技术
J Biol Chem. 2025 Apr;301(4):108363. doi: 10.1016/j.jbc.2025.108363. Epub 2025 Feb 27.
2
Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research.三阴性乳腺癌中雌激素受体β亚型的不同特征:研究进展及对进一步研究的启示
Front Cell Dev Biol. 2023 Oct 23;11:1240386. doi: 10.3389/fcell.2023.1240386. eCollection 2023.
3
Probing the origin of estrogen receptor alpha inhibition large-scale QSAR study.
探究雌激素受体α抑制作用的起源:大规模定量构效关系研究
RSC Adv. 2018 Mar 27;8(21):11344-11356. doi: 10.1039/c7ra10979b. eCollection 2018 Mar 21.
4
Estrogen Receptor β Expression and Its Clinical Implication in Breast Cancers: Favorable or Unfavorable?雌激素受体β在乳腺癌中的表达及其临床意义:有利还是不利?
J Breast Cancer. 2022 Apr;25(2):75-93. doi: 10.4048/jbc.2022.25.e9. Epub 2022 Feb 21.
5
Daidzein Induces Intrinsic Pathway of Apoptosis along with ER α/β Ratio Alteration and ROS Production.大豆苷元通过改变 ERα/β 比值和产生 ROS 诱导细胞发生内在凋亡途径。
Asian Pac J Cancer Prev. 2021 Feb 1;22(2):603-610. doi: 10.31557/APJCP.2021.22.2.603.
6
DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development.诱导DAXX的植物雌激素可抑制雌激素受体阳性肿瘤起始细胞并延缓肿瘤发展。
NPJ Breast Cancer. 2020 Aug 14;6:37. doi: 10.1038/s41523-020-00178-5. eCollection 2020.
7
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer.雌激素受体β在三阴性乳腺癌中的作用研究
Cancers (Basel). 2020 Jun 5;12(6):1477. doi: 10.3390/cancers12061477.
8
The expression of transcription factor BORIS and its association with the estrogen receptor beta (ER-β) in cervical carcinogenesis.转录因子BORIS的表达及其在宫颈癌发生过程中与雌激素受体β(ER-β)的关联。
Int J Clin Exp Pathol. 2019 Sep 1;12(9):3208-3221. eCollection 2019.
9
Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.核雌激素受体β表达对接受新辅助化疗的乳腺癌患者的影响。
Geburtshilfe Frauenheilkd. 2019 Oct;79(10):1110-1117. doi: 10.1055/a-0987-9898. Epub 2019 Oct 22.
10
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues.使用两种经过验证的单克隆抗体优化雌激素受体 β 的免疫组织化学检测,证实其在正常和恶性乳腺组织中的表达。
Breast Cancer Res Treat. 2020 Jan;179(1):241-249. doi: 10.1007/s10549-019-05441-3. Epub 2019 Sep 30.